share_log

一周新股 | 港股IPO市场降温,FF成功登陆纳斯达克

Weekly IPO | Hong Kong stock IPO market cools down, FF successfully lands on NASDAQ

富途資訊 ·  Jul 24, 2021 15:36  · IPO

big

Over the past week, the Hang Seng Index fell 2.44% to 27321.98.

The Hong Kong stock IPO market is relatively deserted, with a total of 5 IPOs this week, including 3 biomedical companies-clinical biopharmaceutical companiesTianguangshu organismAndArnold Pharmaceutical GroupAnd manufacturers of disposable non-latex glovesHuayuan Medical.

There has been no news of new shares or is in the state of offering in the past week, only 1 new stock$San Son Group (06611.HK) $It was listed on the main board of the Hong Kong Stock Exchange, but the performance was mediocre after the listing, closing at HK $4.75 as of Friday, which was flat compared with the share price.

In terms of SPAC, the merger vote between Faraday Future (FF) and American company Property Solutions Acquisition Corp. (PSAC) was formally approved this week and officially landed on NASDAQ on July 22nd. As of Friday's close$Faraday Future Intelligent Electric Inc. (FFIE.US) $It closed at $14.82, with a total market capitalization of $4.8 billion.

logo

There have been five IPOs in the past week.

Tianguangshu organismSino Biopharmaceutical, a clinical company specializing in the discovery and development of differentiated antibody drugs, has developed a differentiated pipeline consisting of 6 clinical drugs and 6 representative preclinical drugs. The company's ADCC enhanced antibody platform is the only self-developed and clinically proven antibody glycosylation modification platform with GMP manufacturing standards in China. At present, the company does not have any products approved or in the stage of commercialization, nor does it generate any revenue from product sales.

Heaven has educationHe is a pioneer and leader in China's large media education service industry, and operates Wuhan Media College, Wuhan Yucai Art Senior Middle School and two high schools featuring art courses (Dawutianyou and Huanggangtianyou). And co-operate a large Media School (Jianghan University School of Design) with Jianghan University.

Arnold Pharmaceutical GroupIs a clinical-stage biopharmaceutical company that focuses on developing innovative cancer treatments for cancer patients at different stages, with the goal of turning cancer into a chronic and eventually curable disease. Its product pipeline includes four clinical drug candidates and seven preclinical drug candidates. At present, the company does not have any products approved for commercial sale and does not generate any revenue from product sales.

Huayuan MedicalIt is a manufacturer and supplier of disposable non-latex gloves with a sales network in more than 50 countries and regions around the world. The company's main products include PVC gloves and nitrile gloves. In 2020, the company ranked eighth in terms of sales revenue of the global PVC glove industry, with a market share of about 1.9%; ranked seventh in China's nitrile glove industry, with a market share of about 1.7%; ranked ninth among Chinese disposable glove manufacturers in terms of sales revenue, with a market share of about 2.3%.

Weili HoldingsIs a cigarette packaging paper manufacturer, the company mainly provides products to cigarette packaging manufacturers operating in various provinces of China, including Hubei Province and Henan Province, whose products are used to manufacture cigarette packaging of well-known Chinese tobacco brands. In terms of sales value in 2020, the company is the largest manufacturer of cigarette packaging paper in Hubei Province, with a market share of about 14.9%.

logo

There has been only one new stock in the past week.$San Son Group (06611.HK) $The motherboard is listed.

Sanson Group's performance was mediocre after its listing, closing at HK $4.75 as of July 23, which was flat compared with its share price.

According to previous public information, the number of applicants for Sanson Group's public placement was 16075, with a success rate of 35%, and four subscriptions were stable in one hand. The company is a Chinese real estate developer headquartered in Shanghai, rooted in Anhui Province and focusing on residential property development and sales.

Edit / Aurora

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment